Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment

Author： Tschoep-Lechner Katharina   Drexler Ingo   Hammer Doreen   Neumann Daniel   Pohla Heike   Sutter Gerd   Noessner Elfriede   Issels Rolf-Dieter  

Publisher： Informa Healthcare

ISSN： 1464-5157

Source： International Journal of Hyperthermia, Vol.28, Iss.1, 2012-02, pp. : 33-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Modified Vaccinia Virus Ankara (MVA) Expressing Wild-Type Human p53 Induces Specific Antitumor CTL Expansion

By Song Guang-Yun   Srivastava Tumul   Ishizaki Hidenobu   Lacey Simon F.   Diamond Don J.   Ellenhorn Joshua D. I.  

Cancer Investigation, Vol. 29, Iss. 8, 2011-09 ,pp. : 501-510

Informa Healthcare

Access to resources Recommend Favorite

Effect of Photoreactivating Light on Virus Infection of UV-exposed Potoroo Cells

By Lytle C.D.   Benane S.G.  

International Journal of Radiation Biology, Vol. 27, Iss. 5, 1975-05 ,pp. : 487-491

Informa Healthcare

Access to resources Recommend Favorite

Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy

By            

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1123-1128

Spandidos Publications

Access to resources Recommend Favorite

31P-Magnetic resonance spectra of ovarian cancer cells exposed to chemotherapy within a three-dimensional Matrigel construct

By          

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 735-741

Spandidos Publications

Access to resources Recommend Favorite

Comments on cultured human sarcoma cells

By Sinkovics Joseph G.  

Sarcoma, Vol. 7, Iss. 2, 2003-06 ,pp. : 75-77

Informa Healthcare

Access to resources Recommend Favorite